Skip to main content
. 2017 Jul 24;12:5271–5287. doi: 10.2147/IJN.S135306

Figure 1.

Figure 1

Schematic illustration of drug loading, cellular entry, drug release, and antitumor mechanism of LHD/miR-375.

Abbreviations: DOX, doxorubicin hydrochloride; HMSN, hollow mesoporous silica nanoparticles; LHD, lipid-coated hollow mesoporous silica nanoparticles containing doxorubicin hydrochloride; MDR, multidrug resistance; MMP, mitochondrial membrane potential; PEG, polyethylene glycol; P-gp, P-glycoprotein.